Leaflet KANAMICINA PANPHARMA 1g powder for solution for injection / infusion

Product code:
W61665001
Quantity:
50
Indicated for:
bacterial infections
Route of administration:
injectable / infusion
Substance:
kanamycin (aminoglycoside antibiotic)
ATC
J01GB04 — Antiinfectives for systemic use | Aminoglycoside antibacterials | Other aminoglycosides

Precautions:

Dose adjustment in renal impairment

Dose adjustment in renal impairment

Dose adjustment may be needed in kidney disease.

Anaphylaxis

Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Colitis / severe diarrhea

Colitis / severe diarrhea

Seek medical advice if severe or persistent diarrhea occurs.

Nephrotoxicity

Nephrotoxicity

This medicine may affect the kidneys.

Ototoxicity

Ototoxicity

This medicine may affect hearing or balance.

Pregnancy warning

Pregnancy warning

Use during pregnancy only on medical advice.

Kanamycin is an aminoglycoside antibiotic used to treat severe bacterial infections such as tuberculosis or abdominal infections. It works by inhibiting bacterial protein synthesis, thereby killing susceptible bacteria.

The medication is usually administered via intramuscular or intravenous injection under medical supervision.

Side effects may include kidney function impairment, hearing loss, or allergic reactions. Long-term use requires careful monitoring to prevent toxicity.

Patients should inform their doctor about any other medications they are taking and avoid concurrent use with other ototoxic or nephrotoxic drugs. Pregnant or breastfeeding women should consult a specialist before use.

General data about KANAMICINA PANPHARMA 1g

Substance:
kanamycin
Date of latest medicines list:
01-03-2022
Product code:
W61665001
Concentration:
1g
Pharmaceutical form:
powder for solution for injection / infusion
Quantity:
50
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
PANPHARMA - FRANTA
Holder:
PANPHARMA - FRANTA
Number:
13176/2020/01
Shelf life:
3 years-after packing for marketing;after reconstitution-it is used immediately

Concentrations available for kanamycin

  • 1%
  • 10mg/g
  • 1g

Combinations with other substances